APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gastrointestinal AI-assisted Diagnosis

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Gastrointestinal AI-assisted Diagnosis Market Analysis and Forecast 2026-2032

6 March 2026197 pages

Choose your research edition.

Industry ResearchGastrointestinal AI-assisted Diagnosis Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Gastrointestinal AI-assisted Diagnosis Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Gastrointestinal AI-assisted Diagnosis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gastrointestinal AI-assisted Diagnosis Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Gastrointestinal AI-assisted Diagnosis Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Gastrointestinal AI-assisted Diagnosis market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Gastrointestinal AI-assisted Diagnosis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Gastrointestinal AI-assisted Diagnosis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Gastrointestinal AI-assisted Diagnosis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Gastrointestinal AI-assisted Diagnosis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Gastrointestinal AI-assisted Diagnosis include Wision, Sense Time, Xiamen inno Medical, Tianjin Yujin artificial intelligence Medical, Surgi-plan, Intelligent Scopes Corp, RSIP Vision and Medtronic, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Gastrointestinal AI-assisted Diagnosis, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Gastrointestinal AI-assisted Diagnosis, also provides the revenue of main regions and countries. Of the upcoming market potential for Gastrointestinal AI-assisted Diagnosis, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gastrointestinal AI-assisted Diagnosis revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Gastrointestinal AI-assisted Diagnosis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Gastrointestinal AI-assisted Diagnosis revenue, projected growth trends, production technology, application and end-user industry.

Gastrointestinal AI-assisted Diagnosis Segment by Company

Wision

Sense Time

Xiamen inno Medical

Tianjin Yujin artificial intelligence Medical

Surgi-plan

Intelligent Scopes Corp

RSIP Vision

Medtronic

Gastrointestinal AI-assisted Diagnosis Segment by Type

Cloud-based

On-Primes

Gastrointestinal AI-assisted Diagnosis Segment by Application

Hospital

Clinic

Imaging Center

Gastrointestinal AI-assisted Diagnosis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gastrointestinal AI-assisted Diagnosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gastrointestinal AI-assisted Diagnosis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gastrointestinal AI-assisted Diagnosis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Gastrointestinal AI-assisted Diagnosis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Gastrointestinal AI-assisted Diagnosis company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gastrointestinal AI-assisted Diagnosis revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Gastrointestinal AI-assisted Diagnosis Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Cloud-based Major Player Table 3. On-Primes Major Player Table 4. Global Gastrointestinal AI-assisted Diagnosis Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Player Table 6. Clinic Major Player Table 7. Imaging Center Major Player Table 8. Gastrointestinal AI-assisted Diagnosis Industry Trends Table 9. Gastrointestinal AI-assisted Diagnosis Industry Drivers Table 10. Gastrointestinal AI-assisted Diagnosis Industry Opportunities and Challenges Table 11. Gastrointestinal AI-assisted Diagnosis Industry Restraints Table 12. Global Gastrointestinal AI-assisted Diagnosis Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Gastrointestinal AI-assisted Diagnosis Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Gastrointestinal AI-assisted Diagnosis Market Share by Region (2021-2026) Table 15. Global Gastrointestinal AI-assisted Diagnosis Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Gastrointestinal AI-assisted Diagnosis Market Share by Region (2027-2032) Table 17. Global Gastrointestinal AI-assisted Diagnosis Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Gastrointestinal AI-assisted Diagnosis Revenue Market Share by Players (2021-2026) Table 19. Global Gastrointestinal AI-assisted Diagnosis Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Gastrointestinal AI-assisted Diagnosis Key Players Headquarters & Area Served Table 21. Global Gastrointestinal AI-assisted Diagnosis Players, Product Type & Application Table 22. Global Gastrointestinal AI-assisted Diagnosis Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Gastrointestinal AI-assisted Diagnosis by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Gastrointestinal AI-assisted Diagnosis Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Gastrointestinal AI-assisted Diagnosis Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Gastrointestinal AI-assisted Diagnosis Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Gastrointestinal AI-assisted Diagnosis Revenue Market Share by Type (2021-2026) Table 29. Global Gastrointestinal AI-assisted Diagnosis Revenue Market Share by Type (2027-2032) Table 30. Global Gastrointestinal AI-assisted Diagnosis Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Gastrointestinal AI-assisted Diagnosis Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Gastrointestinal AI-assisted Diagnosis Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Gastrointestinal AI-assisted Diagnosis Revenue Market Share by Application (2021-2026) Table 34. Global Gastrointestinal AI-assisted Diagnosis Revenue Market Share by Application (2027-2032) Table 35. Wision Company Information Table 36. Wision Business Overview Table 37. Wision Gastrointestinal AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Wision Gastrointestinal AI-assisted Diagnosis Product Portfolio Table 39. Wision Recent Development Table 40. Sense Time Company Information Table 41. Sense Time Business Overview Table 42. Sense Time Gastrointestinal AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Sense Time Gastrointestinal AI-assisted Diagnosis Product Portfolio Table 44. Sense Time Recent Development Table 45. Xiamen inno Medical Company Information Table 46. Xiamen inno Medical Business Overview Table 47. Xiamen inno Medical Gastrointestinal AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Xiamen inno Medical Gastrointestinal AI-assisted Diagnosis Product Portfolio Table 49. Xiamen inno Medical Recent Development Table 50. Tianjin Yujin artificial intelligence Medical Company Information Table 51. Tianjin Yujin artificial intelligence Medical Business Overview Table 52. Tianjin Yujin artificial intelligence Medical Gastrointestinal AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Tianjin Yujin artificial intelligence Medical Gastrointestinal AI-assisted Diagnosis Product Portfolio Table 54. Tianjin Yujin artificial intelligence Medical Recent Development Table 55. Surgi-plan Company Information Table 56. Surgi-plan Business Overview Table 57. Surgi-plan Gastrointestinal AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Surgi-plan Gastrointestinal AI-assisted Diagnosis Product Portfolio Table 59. Surgi-plan Recent Development Table 60. Intelligent Scopes Corp Company Information Table 61. Intelligent Scopes Corp Business Overview Table 62. Intelligent Scopes Corp Gastrointestinal AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Intelligent Scopes Corp Gastrointestinal AI-assisted Diagnosis Product Portfolio Table 64. Intelligent Scopes Corp Recent Development Table 65. RSIP Vision Company Information Table 66. RSIP Vision Business Overview Table 67. RSIP Vision Gastrointestinal AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. RSIP Vision Gastrointestinal AI-assisted Diagnosis Product Portfolio Table 69. RSIP Vision Recent Development Table 70. Medtronic Company Information Table 71. Medtronic Business Overview Table 72. Medtronic Gastrointestinal AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Medtronic Gastrointestinal AI-assisted Diagnosis Product Portfolio Table 74. Medtronic Recent Development Table 75. North America Gastrointestinal AI-assisted Diagnosis Revenue by Type (2021-2026) & (US$ Million) Table 76. North America Gastrointestinal AI-assisted Diagnosis Revenue by Type (2027-2032) & (US$ Million) Table 77. North America Gastrointestinal AI-assisted Diagnosis Revenue by Application (2021-2026) & (US$ Million) Table 78. North America Gastrointestinal AI-assisted Diagnosis Revenue by Application (2027-2032) & (US$ Million) Table 79. North America Gastrointestinal AI-assisted Diagnosis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 80. North America Gastrointestinal AI-assisted Diagnosis Revenue by Country (2021-2026) & (US$ Million) Table 81. North America Gastrointestinal AI-assisted Diagnosis Revenue by Country (US$ Million) & (2027-2032) Table 82. Europe Gastrointestinal AI-assisted Diagnosis Revenue by Type (2021-2026) & (US$ Million) Table 83. Europe Gastrointestinal AI-assisted Diagnosis Revenue by Type (2027-2032) & (US$ Million) Table 84. Europe Gastrointestinal AI-assisted Diagnosis Revenue by Application (2021-2026) & (US$ Million) Table 85. Europe Gastrointestinal AI-assisted Diagnosis Revenue by Application (2027-2032) & (US$ Million) Table 86. Europe Gastrointestinal AI-assisted Diagnosis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 87. Europe Gastrointestinal AI-assisted Diagnosis Revenue by Country (2021-2026) & (US$ Million) Table 88. Europe Gastrointestinal AI-assisted Diagnosis Revenue by Country (US$ Million) & (2027-2032) Table 89. China Gastrointestinal AI-assisted Diagnosis Revenue by Type (2021-2026) & (US$ Million) Table 90. China Gastrointestinal AI-assisted Diagnosis Revenue by Type (2027-2032) & (US$ Million) Table 91. China Gastrointestinal AI-assisted Diagnosis Revenue by Application (2021-2026) & (US$ Million) Table 92. China Gastrointestinal AI-assisted Diagnosis Revenue by Application (2027-2032) & (US$ Million) Table 93. Asia Gastrointestinal AI-assisted Diagnosis Revenue by Type (2021-2026) & (US$ Million) Table 94. Asia Gastrointestinal AI-assisted Diagnosis Revenue by Type (2027-2032) & (US$ Million) Table 95. Asia Gastrointestinal AI-assisted Diagnosis Revenue by Application (2021-2026) & (US$ Million) Table 96. Asia Gastrointestinal AI-assisted Diagnosis Revenue by Application (2027-2032) & (US$ Million) Table 97. Asia Gastrointestinal AI-assisted Diagnosis Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Asia Gastrointestinal AI-assisted Diagnosis Revenue by Region (US$ Million) & (2021-2026) Table 99. Asia Gastrointestinal AI-assisted Diagnosis Revenue by Region (US$ Million) & (2027-2032) Table 100. SAMEA Gastrointestinal AI-assisted Diagnosis Revenue by Type (2021-2026) & (US$ Million) Table 101. SAMEA Gastrointestinal AI-assisted Diagnosis Revenue by Type (2027-2032) & (US$ Million) Table 102. SAMEA Gastrointestinal AI-assisted Diagnosis Revenue by Application (2021-2026) & (US$ Million) Table 103. SAMEA Gastrointestinal AI-assisted Diagnosis Revenue by Application (2027-2032) & (US$ Million) Table 104. SAMEA Gastrointestinal AI-assisted Diagnosis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. SAMEA Gastrointestinal AI-assisted Diagnosis Revenue by Country (2021-2026) & (US$ Million) Table 106. SAMEA Gastrointestinal AI-assisted Diagnosis Revenue by Country (US$ Million) & (2027-2032) Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Gastrointestinal AI-assisted Diagnosis Image Figure 2. Global Gastrointestinal AI-assisted Diagnosis Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gastrointestinal AI-assisted Diagnosis Market Size Share 2021 VS 2025 VS 2032 Figure 4. Cloud-based Image Figure 5. On-Primes Image Figure 6. Global Gastrointestinal AI-assisted Diagnosis Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Gastrointestinal AI-assisted Diagnosis Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Imaging Center Image Figure 11. Global Gastrointestinal AI-assisted Diagnosis Market Size (US$ Million) & (2021-2032) Figure 12. Global Gastrointestinal AI-assisted Diagnosis Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Gastrointestinal AI-assisted Diagnosis Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Gastrointestinal AI-assisted Diagnosis Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Gastrointestinal AI-assisted Diagnosis Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Gastrointestinal AI-assisted Diagnosis Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Gastrointestinal AI-assisted Diagnosis Revenue Market Share by Type (2021-2032) Figure 19. Global Gastrointestinal AI-assisted Diagnosis Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Gastrointestinal AI-assisted Diagnosis Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Gastrointestinal AI-assisted Diagnosis Revenue Market Share by Application (2021-2032) Figure 22. North America Gastrointestinal AI-assisted Diagnosis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Gastrointestinal AI-assisted Diagnosis Revenue Share by Type (2021-2032) Figure 24. North America Gastrointestinal AI-assisted Diagnosis Revenue Share by Application (2021-2032) Figure 25. North America Gastrointestinal AI-assisted Diagnosis Revenue Share by Country (2021-2032) Figure 26. United States Gastrointestinal AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Gastrointestinal AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Gastrointestinal AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Gastrointestinal AI-assisted Diagnosis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Gastrointestinal AI-assisted Diagnosis Revenue Share by Type (2021-2032) Figure 31. Europe Gastrointestinal AI-assisted Diagnosis Revenue Share by Application (2021-2032) Figure 32. Europe Gastrointestinal AI-assisted Diagnosis Revenue Share by Country (2021-2032) Figure 33. Germany Gastrointestinal AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Gastrointestinal AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Gastrointestinal AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Gastrointestinal AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Gastrointestinal AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Gastrointestinal AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Gastrointestinal AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Gastrointestinal AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Gastrointestinal AI-assisted Diagnosis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Gastrointestinal AI-assisted Diagnosis Revenue Share by Type (2021-2032) Figure 43. China Gastrointestinal AI-assisted Diagnosis Revenue Share by Application (2021-2032) Figure 44. Asia Gastrointestinal AI-assisted Diagnosis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Gastrointestinal AI-assisted Diagnosis Revenue Share by Type (2021-2032) Figure 46. Asia Gastrointestinal AI-assisted Diagnosis Revenue Share by Application (2021-2032) Figure 47. Asia Gastrointestinal AI-assisted Diagnosis Revenue Share by Region (2021-2032) Figure 48. Japan Gastrointestinal AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Gastrointestinal AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Gastrointestinal AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Gastrointestinal AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Gastrointestinal AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Gastrointestinal AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Gastrointestinal AI-assisted Diagnosis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Gastrointestinal AI-assisted Diagnosis Revenue Share by Type (2021-2032) Figure 56. SAMEA Gastrointestinal AI-assisted Diagnosis Revenue Share by Application (2021-2032) Figure 57. SAMEA Gastrointestinal AI-assisted Diagnosis Revenue Share by Country (2021-2032) Figure 58. Brazil Gastrointestinal AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Gastrointestinal AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Gastrointestinal AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Gastrointestinal AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Gastrointestinal AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Gastrointestinal AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Gastrointestinal AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Gastrointestinal AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Gastrointestinal AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Gastrointestinal AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Gastrointestinal AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-based
  • On-Primes
Applications
  • Hospital
  • Clinic
  • Imaging Center
Companies covered
  • Wision
  • Sense Time
  • Xiamen inno Medical
  • Tianjin Yujin artificial intelligence Medical
  • Surgi-plan
  • Intelligent Scopes Corp
  • RSIP Vision
  • Medtronic

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Gastrointestinal AI-assisted Diagnosis Market by Type
  3. 1.2.1 Global Gastrointestinal AI-assisted Diagnosis Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Cloud-based
  5. 1.2.3 On-Primes
  6. 1.3 Gastrointestinal AI-assisted Diagnosis Market by Application
  7. 1.3.1 Global Gastrointestinal AI-assisted Diagnosis Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Imaging Center
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Gastrointestinal AI-assisted Diagnosis Market Dynamics
  1. 2.1 Gastrointestinal AI-assisted Diagnosis Industry Trends
  2. 2.2 Gastrointestinal AI-assisted Diagnosis Industry Drivers
  3. 2.3 Gastrointestinal AI-assisted Diagnosis Industry Opportunities and Challenges
  4. 2.4 Gastrointestinal AI-assisted Diagnosis Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Gastrointestinal AI-assisted Diagnosis Market Perspective (2021-2032)
  2. 3.2 Global Gastrointestinal AI-assisted Diagnosis Growth Trends by Region
  3. 3.2.1 Global Gastrointestinal AI-assisted Diagnosis Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Gastrointestinal AI-assisted Diagnosis Market Size by Region (2021-2026)
  5. 3.2.3 Global Gastrointestinal AI-assisted Diagnosis Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Gastrointestinal AI-assisted Diagnosis Revenue by Players
  2. 4.1.1 Global Gastrointestinal AI-assisted Diagnosis Revenue by Players (2021-2026)
  3. 4.1.2 Global Gastrointestinal AI-assisted Diagnosis Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Gastrointestinal AI-assisted Diagnosis Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Gastrointestinal AI-assisted Diagnosis Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Gastrointestinal AI-assisted Diagnosis Key Players Headquarters & Area Served
  7. 4.4 Global Gastrointestinal AI-assisted Diagnosis Players, Product Type & Application
  8. 4.5 Global Gastrointestinal AI-assisted Diagnosis Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Gastrointestinal AI-assisted Diagnosis Market CR5 and HHI
  11. 4.6.3 2025 Gastrointestinal AI-assisted Diagnosis Tier 1, Tier 2, and Tier 3
5 Gastrointestinal AI-assisted Diagnosis Market Size by Type
  1. 5.1 Global Gastrointestinal AI-assisted Diagnosis Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Gastrointestinal AI-assisted Diagnosis Revenue by Type (2021-2032)
  3. 5.3 Global Gastrointestinal AI-assisted Diagnosis Revenue Market Share by Type (2021-2032)
6 Gastrointestinal AI-assisted Diagnosis Market Size by Application
  1. 6.1 Global Gastrointestinal AI-assisted Diagnosis Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Gastrointestinal AI-assisted Diagnosis Revenue by Application (2021-2032)
  3. 6.3 Global Gastrointestinal AI-assisted Diagnosis Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Wision
  2. 7.1.1 Wision Company Information
  3. 7.1.2 Wision Business Overview
  4. 7.1.3 Wision Gastrointestinal AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Wision Gastrointestinal AI-assisted Diagnosis Product Portfolio
  6. 7.1.5 Wision Recent Developments
  7. 7.2 Sense Time
  8. 7.2.1 Sense Time Company Information
  9. 7.2.2 Sense Time Business Overview
  10. 7.2.3 Sense Time Gastrointestinal AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Sense Time Gastrointestinal AI-assisted Diagnosis Product Portfolio
  12. 7.2.5 Sense Time Recent Developments
  13. 7.3 Xiamen inno Medical
  14. 7.3.1 Xiamen inno Medical Company Information
  15. 7.3.2 Xiamen inno Medical Business Overview
  16. 7.3.3 Xiamen inno Medical Gastrointestinal AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Xiamen inno Medical Gastrointestinal AI-assisted Diagnosis Product Portfolio
  18. 7.3.5 Xiamen inno Medical Recent Developments
  19. 7.4 Tianjin Yujin artificial intelligence Medical
  20. 7.4.1 Tianjin Yujin artificial intelligence Medical Company Information
  21. 7.4.2 Tianjin Yujin artificial intelligence Medical Business Overview
  22. 7.4.3 Tianjin Yujin artificial intelligence Medical Gastrointestinal AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Tianjin Yujin artificial intelligence Medical Gastrointestinal AI-assisted Diagnosis Product Portfolio
  24. 7.4.5 Tianjin Yujin artificial intelligence Medical Recent Developments
  25. 7.5 Surgi-plan
  26. 7.5.1 Surgi-plan Company Information
  27. 7.5.2 Surgi-plan Business Overview
  28. 7.5.3 Surgi-plan Gastrointestinal AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Surgi-plan Gastrointestinal AI-assisted Diagnosis Product Portfolio
  30. 7.5.5 Surgi-plan Recent Developments
  31. 7.6 Intelligent Scopes Corp
  32. 7.6.1 Intelligent Scopes Corp Company Information
  33. 7.6.2 Intelligent Scopes Corp Business Overview
  34. 7.6.3 Intelligent Scopes Corp Gastrointestinal AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Intelligent Scopes Corp Gastrointestinal AI-assisted Diagnosis Product Portfolio
  36. 7.6.5 Intelligent Scopes Corp Recent Developments
  37. 7.7 RSIP Vision
  38. 7.7.1 RSIP Vision Company Information
  39. 7.7.2 RSIP Vision Business Overview
  40. 7.7.3 RSIP Vision Gastrointestinal AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  41. 7.7.4 RSIP Vision Gastrointestinal AI-assisted Diagnosis Product Portfolio
  42. 7.7.5 RSIP Vision Recent Developments
  43. 7.8 Medtronic
  44. 7.8.1 Medtronic Company Information
  45. 7.8.2 Medtronic Business Overview
  46. 7.8.3 Medtronic Gastrointestinal AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Medtronic Gastrointestinal AI-assisted Diagnosis Product Portfolio
  48. 7.8.5 Medtronic Recent Developments
8 North America
  1. 8.1 North America Gastrointestinal AI-assisted Diagnosis Revenue (2021-2032)
  2. 8.2 North America Gastrointestinal AI-assisted Diagnosis Revenue by Type (2021-2032)
  3. 8.2.1 North America Gastrointestinal AI-assisted Diagnosis Revenue by Type (2021-2026)
  4. 8.2.2 North America Gastrointestinal AI-assisted Diagnosis Revenue by Type (2027-2032)
  5. 8.3 North America Gastrointestinal AI-assisted Diagnosis Revenue Share by Type (2021-2032)
  6. 8.4 North America Gastrointestinal AI-assisted Diagnosis Revenue by Application (2021-2032)
  7. 8.4.1 North America Gastrointestinal AI-assisted Diagnosis Revenue by Application (2021-2026)
  8. 8.4.2 North America Gastrointestinal AI-assisted Diagnosis Revenue by Application (2027-2032)
  9. 8.5 North America Gastrointestinal AI-assisted Diagnosis Revenue Share by Application (2021-2032)
  10. 8.6 North America Gastrointestinal AI-assisted Diagnosis Revenue by Country
  11. 8.6.1 North America Gastrointestinal AI-assisted Diagnosis Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Gastrointestinal AI-assisted Diagnosis Revenue by Country (2021-2026)
  13. 8.6.3 North America Gastrointestinal AI-assisted Diagnosis Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Gastrointestinal AI-assisted Diagnosis Revenue (2021-2032)
  2. 9.2 Europe Gastrointestinal AI-assisted Diagnosis Revenue by Type (2021-2032)
  3. 9.2.1 Europe Gastrointestinal AI-assisted Diagnosis Revenue by Type (2021-2026)
  4. 9.2.2 Europe Gastrointestinal AI-assisted Diagnosis Revenue by Type (2027-2032)
  5. 9.3 Europe Gastrointestinal AI-assisted Diagnosis Revenue Share by Type (2021-2032)
  6. 9.4 Europe Gastrointestinal AI-assisted Diagnosis Revenue by Application (2021-2032)
  7. 9.4.1 Europe Gastrointestinal AI-assisted Diagnosis Revenue by Application (2021-2026)
  8. 9.4.2 Europe Gastrointestinal AI-assisted Diagnosis Revenue by Application (2027-2032)
  9. 9.5 Europe Gastrointestinal AI-assisted Diagnosis Revenue Share by Application (2021-2032)
  10. 9.6 Europe Gastrointestinal AI-assisted Diagnosis Revenue by Country
  11. 9.6.1 Europe Gastrointestinal AI-assisted Diagnosis Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Gastrointestinal AI-assisted Diagnosis Revenue by Country (2021-2026)
  13. 9.6.3 Europe Gastrointestinal AI-assisted Diagnosis Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Gastrointestinal AI-assisted Diagnosis Revenue (2021-2032)
  2. 10.2 China Gastrointestinal AI-assisted Diagnosis Revenue by Type (2021-2032)
  3. 10.2.1 China Gastrointestinal AI-assisted Diagnosis Revenue by Type (2021-2026)
  4. 10.2.2 China Gastrointestinal AI-assisted Diagnosis Revenue by Type (2027-2032)
  5. 10.3 China Gastrointestinal AI-assisted Diagnosis Revenue Share by Type (2021-2032)
  6. 10.4 China Gastrointestinal AI-assisted Diagnosis Revenue by Application (2021-2032)
  7. 10.4.1 China Gastrointestinal AI-assisted Diagnosis Revenue by Application (2021-2026)
  8. 10.4.2 China Gastrointestinal AI-assisted Diagnosis Revenue by Application (2027-2032)
  9. 10.5 China Gastrointestinal AI-assisted Diagnosis Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Gastrointestinal AI-assisted Diagnosis Revenue (2021-2032)
  2. 11.2 Asia Gastrointestinal AI-assisted Diagnosis Revenue by Type (2021-2032)
  3. 11.2.1 Asia Gastrointestinal AI-assisted Diagnosis Revenue by Type (2021-2026)
  4. 11.2.2 Asia Gastrointestinal AI-assisted Diagnosis Revenue by Type (2027-2032)
  5. 11.3 Asia Gastrointestinal AI-assisted Diagnosis Revenue Share by Type (2021-2032)
  6. 11.4 Asia Gastrointestinal AI-assisted Diagnosis Revenue by Application (2021-2032)
  7. 11.4.1 Asia Gastrointestinal AI-assisted Diagnosis Revenue by Application (2021-2026)
  8. 11.4.2 Asia Gastrointestinal AI-assisted Diagnosis Revenue by Application (2027-2032)
  9. 11.5 Asia Gastrointestinal AI-assisted Diagnosis Revenue Share by Application (2021-2032)
  10. 11.6 Asia Gastrointestinal AI-assisted Diagnosis Revenue by Country
  11. 11.6.1 Asia Gastrointestinal AI-assisted Diagnosis Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Gastrointestinal AI-assisted Diagnosis Revenue by Country (2021-2026)
  13. 11.6.3 Asia Gastrointestinal AI-assisted Diagnosis Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Gastrointestinal AI-assisted Diagnosis Revenue (2021-2032)
  2. 12.2 SAMEA Gastrointestinal AI-assisted Diagnosis Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Gastrointestinal AI-assisted Diagnosis Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Gastrointestinal AI-assisted Diagnosis Revenue by Type (2027-2032)
  5. 12.3 SAMEA Gastrointestinal AI-assisted Diagnosis Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Gastrointestinal AI-assisted Diagnosis Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Gastrointestinal AI-assisted Diagnosis Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Gastrointestinal AI-assisted Diagnosis Revenue by Application (2027-2032)
  9. 12.5 SAMEA Gastrointestinal AI-assisted Diagnosis Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Gastrointestinal AI-assisted Diagnosis Revenue by Country
  11. 12.6.1 SAMEA Gastrointestinal AI-assisted Diagnosis Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Gastrointestinal AI-assisted Diagnosis Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Gastrointestinal AI-assisted Diagnosis Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst